Dr. Barry Dworkin

FDA issues advisory of rare side effects of statin use. As always, you need to consider risk vs benefit

Madely Health Headlines Commentary for February 29, 2012

Source:

FDA Warns on Statin Drugs

 

Related posts:

  1. Are US statin guidelines being too inclusive and leading to overtreatment?
  2. Breast cancer risk from hormone replacement needs perspective when compared to other contributing factors
  3. C. difficile infections do occur in children and can be exacerbated by certain antibiotics
  4. The decision to use cholesterol-lowering statins requires full cardiovascular risk assessment